 |
市场调查报告书
商品编码
1904817
免疫蛋白诊断检测市场规模、份额和成长分析（按检测方法、应用、技术、最终用途、分销管道和地区划分）－2026-2033年产业预测Immunoprotein Diagnostic Testing Market Size, Share, and Growth Analysis, By Test, By Application, By Technology, By End Use, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年，免疫蛋白诊断测试市场规模将达到 96.1 亿美元，到 2025 年将达到 103 亿美元，到 2033 年将达到 179.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.2%。
由于感染疾病和慢性病的增加以及人们对早期检测意识的提高，免疫蛋白诊断检测市场正经历显着增长。酵素免疫分析法(ELISA) 和化学冷光免疫检测等诊断技术的创新提高了基于蛋白质的诊断的准确性和效率。人口老化加剧和医疗费用支出不断增长也是推动市场扩张的因素。然而，预算限制和严格的法规结构等潜在挑战可能会阻碍市场成长。儘管如此，对可靠、快速的诊断解决方案的强劲需求（这些解决方案对于有效的疾病管理和明智的治疗决策至关重要）是整体趋势的核心，并推动市场在医疗保健领域持续发展。
免疫蛋白诊断检测市场成长要素
免疫蛋白诊断测试市场成长的主要驱动因素是感染疾病、自体免疫疾病和感染疾病等多种健康问题至关重要。此外，人们对早期诊断重要性的认识不断提高，以及诊断技术的进步，也推动了对这些测试的需求。该领域认知的不断提高和创新正在促进免疫蛋白诊断测试行业的扩张。
免疫蛋白诊断检测市场的限制因素
免疫蛋白诊断检测市场面临的主要限制因素是这些诊断检测的开发和实施过程复杂且高成本。建构可靠且特异性的检测方法需要大量的研究、开发和检验工作，这会耗费大量时间和资源。此外，这些检测的成本和可近性在资源有限的医疗机构中构成障碍，难以广泛应用。这种情况可能会限制检测的普及，并最终阻碍市场成长潜力。因此，这些挑战持续影响着整个产业的进步和发展。
免疫蛋白诊断测试市场趋势
免疫蛋白诊断检测市场呈现显着成长趋势，这主要得益于感染疾病和慢性病发病率上升，导致对精准诊断解决方案的需求激增。多重免疫检测平台和就地检验（POCT）等技术创新能够提供更快、更精确的检测结果，进而提高临床决策的准确性。此外，对个人化医疗和生物标记研究的日益重视也促进了这些诊断检测的广泛应用。同时，相关人员和研究机构之间的策略合作正在推动创新，并支持调查方法的进步，最终推动整个免疫蛋白诊断领域的扩张。
目录
介绍
- 调查目标
- 调查范围
- 定义
调查方法
- 资讯收集
- 二手资料和一手资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 市场吸引力指数（2025）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
全球免疫蛋白质诊断检测市场规模（按检测类型和复合年增长率划分）（2026-2033 年）
- 补体系统蛋白诊断测试
- 游离轻链诊断测试
- 肝珠蛋白诊断测试
- 免疫球蛋白诊断试验
- 前白蛋白诊断试验
- C反应蛋白（CRP）诊断试验
全球免疫蛋白质诊断检测市场规模（按应用领域及复合年增长率划分）（2026-2033 年）
- 传染病检查
- 肿瘤检测
- 内分泌检查
- 毒理学测试
- 过敏测试
- 自体免疫疾病检测
全球免疫蛋白质诊断检测市场规模（依技术及复合年增长率划分）（2026-2033 年）
- 免疫测量
- 酵素免疫分析法
- 化学冷光法
- 萤光
- 免疫比浊法
- 免疫蛋白电泳
全球免疫蛋白质诊断检测市场规模（按最终用途和复合年增长率划分）（2026-2033 年）
- 医院和诊所
- 诊断检查室
- 其他的
全球免疫蛋白诊断检测市场规模（依通路划分）及复合年增长率（2026-2033 年）
- 直接竞标
- 零售
全球免疫蛋白诊断检测市场规模及复合年增长率（2026-2033）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
- 主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较
主要企业简介
- Abbott Laboratories（USA）
- Roche Diagnostics（Switzerland）
- Siemens Healthineers（Germany）
- Thermo Fisher Scientific（USA）
- Danaher Corporation（USA）
- Eurofins Scientific（Luxembourg）
- Qiagen NV（Netherlands）
- Fujifilm Holdings Corporation（Japan）
- DiaSorin SpA（Italy）
- Bio-Rad Laboratories, Inc.（USA）
- Sekisui Medical Corporation（Japan）
- Ortho Clinical Diagnostics（USA）
- Beckman Coulter, Inc.（USA）
- Myriad Genetics, Inc.（USA）
- Alere Inc.（USA）
- Quest Diagnostics Incorporated（USA）
- LabCorp（USA）
- BioMerieux SA（France）
- ARUP Laboratories（USA）
- MSD（Merck & Co., Inc.）（USA）
结论与建议
Immunoprotein Diagnostic Testing Market size was valued at USD 9.61 Billion in 2024 and is poised to grow from USD 10.3 Billion in 2025 to USD 17.96 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
The immunoprotein diagnostic testing market is experiencing considerable growth, fueled by the rise in infectious and chronic diseases and heightened awareness surrounding early detection. Innovations in diagnostic technologies, like enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays, have enhanced the precision and efficiency of protein-based diagnostics. The expanding elderly population and increased healthcare spending are additional factors contributing to market expansion. However, potential challenges such as budget limitations and strict regulatory frameworks may hinder growth. Nevertheless, the overarching trend centers on the strong demand for reliable and swift diagnostic solutions, essential for effective disease management and informed therapeutic decisions, positioning the market for continued progression in the healthcare landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoprotein Diagnostic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Immunoprotein Diagnostic Testing Market Segments Analysis
Global Immunoprotein Diagnostic Testing Market is segmented by test, application, technology, end use, distribution channel and region. Based on test, the market is segmented into complement system proteins diagnostic tests, free light chain diagnostic tests, haptoglobin diagnostic tests, immunoglobulin diagnostic tests, prealbumin diagnostic tests andc-reactive protein (CRP) diagnostic tests. Based on application, the market is segmented into infectious disease testing, oncology testing, endocrine testing, toxicology testing, allergy testing and autoimmune disease testing. Based on technology, the market is segmented into radioimmunoassay, enzyme based immunoassay, chemiluminescence assay, immunofluorescence assay, immunoturbidity assay and immunoprotein electrophoresis. Based on end use, the market is segmented into hospitals and clinics, diagnostic laboratories and others. Based on distribution channel, the market is segmented into direct tender and retail sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Immunoprotein Diagnostic Testing Market
A key factor influencing the growth of the immunoprotein diagnostic testing market is the rising incidence of both infectious and chronic illnesses, which significantly heightens the need for precise and prompt diagnostic solutions. Immunoprotein assays are essential for detecting various health issues, including cancers, autoimmune diseases, and infections. Additionally, the growing recognition of the importance of early diagnosis, combined with advancements in diagnostic technology, is driving the demand for these tests. This heightened awareness and innovation in the field are collectively contributing to the expansion of the immunoprotein diagnostic testing sector.
Restraints in the Immunoprotein Diagnostic Testing Market
A major limitation affecting the Immunoprotein Diagnostic Testing market is the intricate and expensive nature of creating and executing these diagnostic tests. Crafting reliable and specific tests demands extensive research, development, and validation efforts, which can be both time-consuming and resource-heavy. Additionally, the cost and availability of these tests present obstacles in healthcare environments with limited resources, making it difficult for them to gain widespread acceptance. This situation could restrict their adoption and ultimately inhibit the growth potential of the market. Consequently, these challenges continue to impact the overall progress and expansion of the industry.
Market Trends of the Immunoprotein Diagnostic Testing Market
The immunoprotein diagnostic testing market is experiencing notable growth trends driven by a surge in the need for accurate diagnostic solutions amid rising infectious and chronic disease rates. Innovations in technology, including multiplex immunoassay platforms and point-of-care testing, are facilitating quicker and more precise outcomes, enhancing clinical decision-making. The increasing emphasis on personalized medicine and biomarker research is also contributing to the widespread adoption of these diagnostic tests. Furthermore, strategic collaborations between industry stakeholders and research entities are fostering innovation, propelling advancements in testing methodologies, and ultimately driving the overall expansion of the immunoprotein diagnostic landscape.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Immunoprotein Diagnostic Testing Market Size by Test & CAGR (2026-2033)
- Market Overview
- Complement System Proteins Diagnostic Tests
- Free Light Chain Diagnostic Tests
- Haptoglobin Diagnostic Tests
- Immunoglobulin Diagnostic Tests
- Prealbumin Diagnostic Tests
- C-Reactive Protein (Crp) Diagnostic Tests
Global Immunoprotein Diagnostic Testing Market Size by Application & CAGR (2026-2033)
- Market Overview
- Infectious Disease Testing
- Oncology Testing
- Endocrine Testing
- Toxicology Testing
- Allergy Testing
- Autoimmune Disease Testing
Global Immunoprotein Diagnostic Testing Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Radioimmunoassay
- Enzyme Based Immunoassay
- Chemiluminescence Assay
- Immunofluorescence Assay
- Immunoturbidity Assay
- Immunoprotein Electrophoresis
Global Immunoprotein Diagnostic Testing Market Size by End Use & CAGR (2026-2033)
- Market Overview
- Hospitals And Clinics
- Diagnostic Laboratories
- Others
Global Immunoprotein Diagnostic Testing Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct Tender
- Retail Sales
Global Immunoprotein Diagnostic Testing Market Size & CAGR (2026-2033)
- North America (Test, Application, Technology, End Use, Distribution Channel)
- USA
- Canada
- Europe (Test, Application, Technology, End Use, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Test, Application, Technology, End Use, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Test, Application, Technology, End Use, Distribution Channel)
- Brazil
- Rest of Latin America
- Middle East & Africa (Test, Application, Technology, End Use, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)
Key Company Profiles
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sekisui Medical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ortho Clinical Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Myriad Genetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alere Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LabCorp (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ARUP Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MSD (Merck & Co., Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
